Published in Nutr Metab (Lond) on November 25, 2015
Prevalence of vitamin D deficiency and association with metabolic syndrome in a Qatari population. Nutr Diabetes (2017) 0.75
Maternal vitamin D depletion alters DNA methylation at imprinted loci in multiple generations. Clin Epigenetics (2016) 0.75
Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser (2000) 70.59
Vitamin D deficiency. N Engl J Med (2007) 59.34
Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2011) 23.10
Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation (2007) 12.79
Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr (2000) 11.69
High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc (2006) 8.78
Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab (2005) 5.64
Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation (1999) 5.04
Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care (2003) 4.23
Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes (2008) 4.11
Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes (2004) 4.04
Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care (2009) 3.20
A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab (2001) 3.16
Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: effects of race, sex, and disease. Am J Clin Nutr (1996) 3.06
Assessing adiposity: a scientific statement from the American Heart Association. Circulation (2011) 3.00
Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med (2013) 2.73
Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr (2009) 2.71
Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Intern Med (2004) 2.50
Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab (2012) 2.41
Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension (1998) 2.20
Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring) (2012) 2.05
The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obes (Lond) (2011) 1.90
PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses (2003) 1.85
Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr (1981) 1.79
Body fat and vitamin D status in black versus white women. J Clin Endocrinol Metab (2004) 1.66
Waist circumference and abdominal adipose tissue distribution: influence of age and sex. Am J Clin Nutr (2005) 1.64
Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence. Diabetes Metab (2005) 1.44
Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int (2003) 1.36
Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol (2008) 1.32
1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells. Diabetes Metab Res Rev (2008) 1.32
1alpha,25-Dihydroxyvitamin D3 modulates human adipocyte metabolism via nongenomic action. FASEB J (2001) 1.29
The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects. Clin Endocrinol (Oxf) (2010) 1.29
Vitamin D inadequacy in postmenopausal women in Eastern Asia. Curr Med Res Opin (2008) 1.24
Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trial control groups. J Hypertens (2002) 1.18
Patterns of osteocalcin and bone specific alkaline phosphatase by age, gender, and race or ethnicity. Bone (2002) 1.18
The cutoff values of visceral fat area and waist circumference for identifying subjects at risk for metabolic syndrome in elderly Korean: Ansan Geriatric (AGE) cohort study. BMC Public Health (2009) 1.12
Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance. Diabetes Care (2001) 1.08
Vitamin D in overweight/obese women and its relationship with dietetic and anthropometric variables. Obesity (Silver Spring) (2009) 1.03
Evaluation of metabolic syndrome risk in Korean premenopausal women: not waist circumference but visceral fat. Circ J (2008) 1.01
Associations between abdominal fat and body mass index on vitamin D status in a group of Spanish schoolchildren. Eur J Clin Nutr (2010) 1.01
Serum 25(OH)D is inversely associated with metabolic syndrome risk profile among urban middle-aged Chinese population. Nutr J (2012) 0.93
Vitamin D3 and the risk of CVD in overweight and obese women: a randomised controlled trial. Br J Nutr (2012) 0.92
Comparisons of body-composition prediction accuracy: a study of 2 bioelectric impedance consumer devices in healthy Chinese persons using DXA and MRI as criteria methods. J Clin Densitom (2011) 0.90
Estimate of a predictive cut-off value for serum 25-hydroxyvitamin D reflecting abdominal obesity in Korean adolescents. Nutr Res (2012) 0.90
Vitamin D, metabolic dyslipidemia, and metabolic syndrome in rheumatoid arthritis. Am J Med (2012) 0.90
Adiposity measures and vitamin D concentrations in Northeast Germany and Denmark. Nutr Metab (Lond) (2015) 0.89
Association of low muscle mass and combined low muscle mass and visceral obesity with low cardiorespiratory fitness. PLoS One (2014) 0.88
Association of visceral fat area with chronic kidney disease and metabolic syndrome risk in the general population: analysis using multi-frequency bioimpedance. Kidney Blood Press Res (2015) 0.87
The effect of body mass index on optimal vitamin D status in U.S. adults: the National Health and Nutrition Examination Survey 2001-2006. Ann Epidemiol (2013) 0.87
Association between serum vitamin D, parathyroid hormone and metabolic syndrome in middle-aged and older Korean adults. Eur J Clin Nutr (2014) 0.86
Associations of serum 25-hydroxyvitamin D3 levels with visceral adipose tissue in Chinese men with normal glucose tolerance. PLoS One (2014) 0.85
Serum 25-hydroxyvitamin D is a predictor of serum 1,25-dihydroxyvitamin D in overweight and obese patients. J Nutr (2010) 0.83
Measurement of visceral fat by abdominal bioelectrical impedance analysis is beneficial in medical checkup. Obes Res Clin Pract (2008) 0.82
Effect of vitamin D2 on hormone-stimulated lipolysis in vitro. Eur J Pharmacol (1969) 0.81
The relationship between metabolic syndrome and increase of metabolic syndrome score and serum vitamin D levels in Korean adults: 2012 Korean National Health and Nutrition Examination Survey. J Clin Biochem Nutr (2015) 0.76
Critical assessment of high-circulation print newspaper coverage of the Institute of Medicine report Dietary Reference Intakes for Calcium and Vitamin D. Public Health Nutr (2013) 0.76